FEATURED ARTICLES

• Dr. Bobby Gaspar On Manufacturing, Commercialization Challenges

  Orchard Therapeutics CEO Dr. Bobby Gaspar, M.D., Ph.D. is one of only a handful of gene therapy leaders to see the light of market-approved therapy. Here, he offers advice for those seeing manufacturing, regulatory, and reimbursement challenges for the first time.

• Single Molecule Measurement: Best Practices In Biomarker Detection
• How Do I Get My Compound Into Phase I?
• Hamilton Robotics Launches Highly Flexible PCR Setup Workstation
• BioReliance Acquires Rights To Big Blue Colonies And Cell Lines From Agilent